Moreover, in PCa cell lines, the AR antagonist bicalutamide (BCT) increased ARO expression and ERβ transcriptional activity; indeed, in CRPC, ARO expression was significantly increased in tumor samples. Here, ESR2 is linked to posterior cortical atrophy.